Insider · CIK 0001312622

Foster-Cheek Kaye I

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001312622

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,927 sh	—	—	2,927
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,816 sh	—	—	0
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	14,950
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,816 sh	—	—	10,284
2026-06-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−39.1K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,006 sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,510
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,120 sh	—	—	0
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,120 sh	—	—	7,468
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,816 sh	—	—	2,816
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,768
2025-06-04	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,774
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,120 sh	—	—	2,120
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−3,388 sh	—	—	0
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.G Gift	Director	GGift	−3,564 sh	—	—	5,348
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,388 sh	—	—	8,912
2024-06-12	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-03-07	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,285 sh	$31.62	−$40.6K	5,524
2024-03-06	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,415 sh	$31.99	−$141K	6,809
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−300 sh	$32.21	−$9,663	11,224
2023-08-09	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	4,307
2023-08-09	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−25K sh	$25.96	−$649K	11,524
2023-08-09	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$18.09	+$452K	36,524
2023-06-21	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,975 sh	—	—	11,524
2023-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Director	MExercise/Conversion	−4,975 sh	—	—	0
2023-06-14	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+19K sh	—	—	18,958
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+3,388 sh	—	—	3,388
2023-01-13	AGIOAGIOS PHARMACEUTICALS, INC.G Gift	Director	GGift	−2,200 sh	—	—	6,549
2022-10-19	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+29.3K sh	—	—	29,307
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Director	AAward	+4,975 sh	—	—	4,975
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Director	MExercise/Conversion	−1,585 sh	—	—	0
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,585 sh	—	—	8,749
2021-05-28	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,686 sh	—	—	0
2021-05-28	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,686 sh	—	—	7,164
2021-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Director	AAward	+1,585 sh	—	—	1,585
2021-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+8,888 sh	—	—	8,888
2020-05-29	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,878 sh	—	—	0
2020-05-29	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,878 sh	—	—	5,478
2020-05-28	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+1,686 sh	—	—	1,686
2020-05-28	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+8,096 sh	—	—	8,096
2019-05-31	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,400 sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
Foster-Cheek Kaye I0001439222-26-000103
SEC(opens sec.gov)
Jun 84
Foster-Cheek Kaye I0001628280-26-041566
SEC(opens sec.gov)
Aug 54
Foster-Cheek Kaye I0001894562-25-000046
SEC(opens sec.gov)
Jun 234
Foster-Cheek Kaye I0001439222-25-000057
SEC(opens sec.gov)
Jun 54
Foster-Cheek Kaye I0001628280-25-029770
SEC(opens sec.gov)
Jun 244
Foster-Cheek Kaye I0001439222-24-000105
SEC(opens sec.gov)

Companies

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139